1 January 2023 false No description of principal activity Taxfiler 2023.15 10253524business:PrivateLimitedCompanyLtd2023-01-012023-12-31 102535242022-12-31 102535242023-01-012023-12-31 10253524business:AuditExempt-NoAccountantsReport2023-01-012023-12-31 10253524business:FilletedAccounts2023-01-012023-12-31 102535242023-12-31 10253524business:Director12023-01-012023-12-31 10253524business:RegisteredOffice2023-01-012023-12-31 102535242022-12-31 10253524core:WithinOneYear2023-12-31 10253524core:WithinOneYear2022-12-31 10253524core:SharePremiumcore:PreviouslyStatedAmount2023-12-31 10253524core:SharePremiumcore:PreviouslyStatedAmount2022-12-31 10253524core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 10253524core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-12-31 10253524core:PreviouslyStatedAmount2023-12-31 10253524core:PreviouslyStatedAmount2022-12-31 10253524business:SmallEntities2023-01-012023-12-31 10253524countries:EnglandWales2023-01-012023-12-31 10253524core:PlantMachinery2023-01-012023-12-31 10253524core:PlantMachinery2022-12-31 10253524core:PlantMachinery2023-12-31 102535242022-01-012022-12-31 iso4217:GBP xbrli:pure
Company Registration No. 10253524 (England and Wales)
Opportunity Pharma Ltd Unaudited accounts for the year ended 31 December 2023
Opportunity Pharma Ltd Unaudited accounts Contents
Page
- 2 -
Opportunity Pharma Ltd Company Information for the year ended 31 December 2023
Director
DR DAVID EDWARD LEAHY
Company Number
10253524 (England and Wales)
Registered Office
c/o WOCO Limited Mereside Alderley Park Alderley Edge Cheshire SK10 4TG United Kingdom
- 3 -
Opportunity Pharma Ltd Statement of financial position as at 31 December 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
- 
3,634 
Current assets
Debtors
541 
103 
Cash at bank and in hand
15,761 
27,483 
16,302 
27,586 
Creditors: amounts falling due within one year
(3,384)
(777)
Net current assets
12,918 
26,809 
Net assets
12,918 
30,443 
Capital and reserves
Share premium
150,162 
150,162 
Profit and loss account
(137,244)
(119,719)
Shareholders' funds
12,918 
30,443 
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 March 2024 and were signed on its behalf by
DR DAVID EDWARD LEAHY Director Company Registration No. 10253524
- 4 -
Opportunity Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
1
Statutory information
Opportunity Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 10253524. The registered office is c/o WOCO Limited, Mereside, Alderley Park, Alderley Edge, Cheshire, SK10 4TG, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
over 5 years
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 January 2023
8,697 
Disposals
(8,697)
At 31 December 2023
- 
Depreciation
At 1 January 2023
5,063 
On disposals
(5,063)
At 31 December 2023
- 
Net book value
At 31 December 2023
- 
At 31 December 2022
3,634 
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
VAT
541 
103 
- 5 -
Opportunity Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Trade creditors
2,607 
- 
Loans from directors
777 
777 
3,384 
777 
7
Average number of employees
During the year the average number of employees was 1 (2022: 1).
- 6 -